Revolutionary Healing Technology for Treating Difficult and Chronic Wounds Approved by Health Canada

06.06.2008 21:00:07
Insense Ltd.: Toronto, Canada (ots/PRNewswire) - Archimed, the woundcare division of Insense Ltd., today announced it has received approval from Health Canada for the use of its revolutionary Oxyzyme product in the treatment of difficult and chronic wounds. Oxyzyme was first trialed in Toronto by Dr. Gary Sibbald, one of the world's leading wound care specialists, in 2004 by his team at the Toronto Wound Healing Centres. The announcement was made at ...

Lesen Sie hier weiter... |  Drucken |  PDF

Ähnliche Artikel




Bankkaufmann - News

Revolutionary Healing Technology for Treating Difficult and Chronic Wounds Approved by Health Health Canada for the use of its revolutionary Oxyzyme


ots.at: das APA-OTS-Portal für multimediale Presseaussendungen

ots.at: das APA-OTS-Portal für multimediale Presse Revolutionary Healing Technology for Treating Difficult and Chronic Wounds Approved by Health


Pressemitteilungen und Pressemeldungen vom 06.06.2008 | PresseEcho.de

Pressemeldungen vom 06.06.2008, PresseEcho.de - Pressemeldungen und News.Taeglich aktuelle Meldungen aus Healing Technology for Treating Difficult


Presseportal: Insense Ltd.

Revolutionary Healing Technology for Treating Difficult and Chronic Wounds Approved by Health from Health Canada for the use of its revolutionary Oxyzyme


Presseportal: Meldung versenden

Revolutionary Healing Technology for Treating Difficult and Chronic Wounds Approved by Health E-Mail-Adresse des Empfängers: Sie können max.5 Empfänger angeben.